Member Info for alfista

Tiddler gone through Nex at .39
You could be right sphinx

Why would they raise the Bid by 11% with not a trade in sight?
Must be something.
Trying to cheer les miserables up?
Won't work

Good news indeed.
To have the company overheads covered by income will be a very stabilising factor. Achieving that from only one well, with all the rest of the acreage to come, speak volumes about future potential. Pantheon are well overdue some good luck IMHO

So soon after an easy placing that leaves the company fully funded ?

Seriously?

Barrell, scraping sound.
Strewth

Not a heart product.
Bloodflow affect the whole body.
Permanent vindictive anger can't be good for you.

Better trade in the Amstrad then.

Fruitflow came straight up on a fast search. £19.99 a pack

Don't see that it has any relevance to Provexis at all.
None of those companies has ever been see as connected in any way. The information doesn't say whether Mr B was in an executive role, or a non exec director. They were Ltd companies, not market quoted.

Have fun neggies.

In a long list of evidence free claims, that one takes the biscuit.

I suspect that there are a few folks with a sense of humour, or perhaps irony.

Must be very tiring keeping up the continuous state of offended indignation.
Keep it up, it's enjoyable.

Well, taken at face value, I don't know what ironice means, but I think the question of whether a CEO can become a CEO is a philosophical conundrum. If a CEO is a CEO, he or she is a CEO and that is continuous until an ex CEO is a more appropriate term.
Bit deep for me.

Quite ironic that, you trying to bully me off the board whilst playing the victim. Classic!

If you read back to the RNS's post demerger, you'll see what happened, all ever so clear.

I couldn't wind you up, you do it all by yourself.
:0(

Quite why you feel the need to pursue your point of view in such a vindictive way I can't imagine.
You criticize those who post that they have bought, but then you did proudly announce when you sold.
Puk, I spelled out tasks that were under the control of the FD, and which were carried out. Quite a belter you came out with there, stating that a FD can't be a CEO. Most CEO's come to the job via FD or lawyer qualifications. Did you think there was a CEO training academy? As ever, it is evidence free criticism.

Go in search of your ideal company, the criteria appears to be this : The company must instantly become profitable after you have bought shares, the shares must gain value regardless of what the Mcap was when you bought, and the personnel of the company must maintain themselves on minimum wage until you have made your gain for doing nothing.

Best of British in your search.

Seriously?
You very clearly have never spoken to him, otherwise you would realise the depth of his knowledge and skillset.
As things progress, his correct title should be CEO.
IMHO

The funding requirement was dealt with.
Liaison with prospective brands asking for the science, dealt with.
Liaison with By Health, and their scientific section completing Blue Hat approval test, dealt with.
Contact with part time brand manager and PR consultant, dealt with.
Numerous return calls to holders, dealt with.
All regulatory and patent issues as needed, dealt with.

Under control, agree Kievsky.

Well I've read your posts recently, and you seem to be fighting yourself over what you think of it all, so I'm confused that you believe a market listing is even possible. Unless you are Daz or Wullie there seems to be little prospect of a financial gain IMHO

Could you enlighten us on where you see the "hard work" going on?
So far, WHET has made one buy of shares in an illiquid Swiss market quoted company, with so little movement that it's hard to argue against that buy being locked in.

Other than that....zilch.

The total asset value is less than 1p a share, arguably much less. So why do you think it would boom on a main market listing? NEX turned it down, and that is a very small, non prestigious market.

Or did you just write that out of vague hope?

Well we are in a period very shortly after a fund raising, which appears to have been supported by a new major holder. Other than that there has been little volume either way, the last buy of Friday raised the Ask but left the Bid where it was. how you view that is probably the key. I've added modestly, main funds still being diverted to a property requirement.
The link posted by sphinx is highly relevant IMHO, apparently Chinese companies have now bought all but one of the major health product retailers in Oz, and of course H&B changed hands not so long ago. The resources poured in to Fruitflow AT NO COST to Provexis is considerable, and By Health have proved themselves capable of marketing new launches in a very bold, ambitious way. By Health shares are soaring, they are on a massive uptrend, giving them the financial clout to really boost sales, and to buy up brands. Their own scientist is a Provexis trained man, his links to the science and the key scientific people is top rate. They do need time to implement the "proven in China" strategy to achieve top status in regulations, that may argue for a no hurry approach if you think there is nothing else happening. H&B are capable of aggressive marketing, those who misunderstand their marketing do so deliberately IMHO. So Fruitflow + has two shots at growth, H&B and USA online launch.

Revenues need to grow, there are several factors that could achieve that. If the growth becomes "many multiples" then clearly breakeven and profit lines could be crossed quickly.

Some believe it can happen, some don't, all a matter of personal interpretation
I'd encourage others to take up some of IF's time to run over the important elements of the last update, the man has an immense knowledge of the various key factors.

Provexis hold the IP, the most valuable part, so they are by no means the weakest partner. At the expiry of the Alliance Agreement, Provexis could elect to organise the production (already carried out by a third party), and marketing themselves, starting off with volumes established to date. If multiples of current revenues have been established, that could be budgeted for.

I don't believe that will happen but it demonstrates that the company is not weak in negotiation stance, far from it.

As for value in a buy out scenario, imagine that revenues had grown to millions, with prospects of further volume increases off the back of more, and bigger, product launches? The current mcap looks plain silly if that prospect develops IMHO, being the value at tickover.

That's the point, multiply current revenues, even a modest multiple, and the whole character of the company changes.
I guess it depends on who believes it possible, and who not.
Invest accordingly, personal choice.

Standard practice.
No more, no less.
Mr Ford said he was more then happy to make a presentation to attendees at the meeting, going over the same points that he discussed with me. Basically interpreting, and fleshing out, the key factors of the last update. So far, no one has said whether they took advantage of that offer, I hope they did, because that guy sure has a comprehensive knowledge of this company that is indispensable IMHO. Several facts reinforce the introduction of "many multiples of the current revenues" in to the vocabulary.
I note that Percy was discussing the company being "taken out on the cheap" on the wasteland board. I have to say, all serious participants, right to the top, share the same view. To paraphrase, if we are going to start that discussion, we really don't want to be starting from the current levels. No sign at all of anyone continuing to stake build at the moment, so my position remains that it is a distant possibility and no more than that.